English home · Practice areas · News · Enquire · Deutsch
This page concerns German law and applicable EU rules. Foreign-law questions require separate assessment.
Veterinary medicine combines individual animal care with business, professional and medicinal-product obligations. We advise veterinary practices and clinics, manufacturers, distributors and animal businesses on contracts, products, regulatory proceedings and liability. We also assist owners with legal assessment of treatment or invoices.
On this page
Considering treatment and product regulation together · Treatment agreements, instructions and informed consent · Treatment errors and veterinary liability · Veterinary invoices, the GOT and fee agreements · Veterinary medicines: identifying the product · Authorisation, manufacture and wholesale distribution · Veterinary dispensaries, supply and administration · Antibiotics and business records · Advertising, professional audiences and treatment outcomes · Online sales and cross-border distribution · Adverse reactions, quality defects and recalls · Practice management, cooperation and business development · Authorities, civil courts and defence · Preparing for advice
Considering treatment and product regulation together
An incident may involve several causes and responsible parties: a treatment decision, inadequate records, a disputed medicine or incorrect administration. These issues require separate assessment. An unsuccessful treatment does not automatically establish negligence or a product defect.
We first establish whether the matter concerns an individual patient, practice operations, a product launch or distribution. We then identify the parties, legal issues and documents needed. Veterinary experts can address medical questions where necessary.
Treatment agreements, instructions and informed consent
For diagnostic and therapeutic measures, instructions, the treatment situation and communication with the owner matter. Questions include who instructed the vet, what examinations were agreed, and what information on risks, alternatives and costs was required. An emergency may require a different assessment from a planned procedure.
We help practices establish clear contractual and record-keeping processes. Herd care, reproductive medicine, equine examinations and business services particularly require precise scope and responsibilities. Blanket exclusions of liability do not replace careful drafting.
Treatment errors and veterinary liability
The relevant professional standard, possible breach, causation and loss are decisive. Certain errors may justify evidential presumptions or changes to the burden of proof, but not merely because an animal died or needed another operation.
We organise the treatment chronology, review records and coordinate with liability insurers. Treatment expenses, consequential costs and other losses require individual assessment. Independent evidence proceedings may help preserve changing findings or clarify technical and medical issues early.
Veterinary invoices, the GOT and fee agreements
Veterinary billing must take the GOT fee schedule into account. Assessment requires individual services, fee multipliers, expenses, medicines, timing and special circumstances. Comparing totals from different treatments is not a reliable assessment by itself.
We advise on cost communication, permissible agreements, invoice objections and debt recovery. Medical objections must be distinguished from billing objections. Initial assessment requires the full invoice, instructions, cost information and, where appropriate, treatment records.
Veterinary medicines: identifying the product
Regulation (EU) 2019/6 and Germany’s Veterinary Medicinal Products Act provide key legal foundations. Classification depends on composition, effect, intended purpose and presentation. The supplier’s name for a product is not decisive.
Borderline questions arise with complementary feeds carrying health claims, care products, biocides and veterinary technical products. Combining an article with a medicine can create specific requirements. Classification should be established before packaging and advertising are finalised.
Authorisation, manufacture and wholesale distribution
For market entry we assess regulatory status, required authorisations or other product conditions and the roles of the businesses involved. Manufacture, import and distribution may also require business-level permits. Product authorisation and the business’s entitlement to operate are separate questions.
Contract manufacturing, quality responsibility, supply chains and changes to existing products should be coordinated contractually and operationally. Legal advice does not replace scientific documentation, quality testing or the authority’s decision. Cross-border projects should identify the target market at the outset.
Veterinary dispensaries, supply and administration
Procurement, storage, supply and administration of veterinary medicines are subject to different requirements. Practices need clear responsibilities, records and staffing arrangements. Use outside a standard authorisation requires careful assessment of the relevant conditions and limits.
Food-producing animals require particular care. For horses, the relevant status must be checked against the applicable documents. Withdrawal periods, records and restrictions must not be transferred from other species without assessment.
Antibiotics and business records
Antimicrobial medicines involve additional restrictions and documentation duties. Reporting depends on species, use, the party’s role and the relevant reporting period. Veterinary duties and animal keeper duties must be distinguished.
For 2026, expanded data collection covering additional species is particularly relevant. Our article on antibiotic reporting for horses and other species explains the timing. We assist with legal assessment of processes and complaints without pre-empting clinical treatment decisions.
Advertising, professional audiences and treatment outcomes
Veterinary medicine advertising must comply with applicable product information and statutory requirements. Exaggerated or misleading efficacy claims are problematic. Prescription products have particular restrictions on the audiences to whom advertising may be directed.
Product pages, advertisements, webinars and adopted testimonials should be reviewed together. Veterinary recommendations and customer accounts do not replace substantiation. Claims of superiority require especially robust support. We assist with advertising review, warning letters and injunction proceedings.
Online sales and cross-border distribution
Permissible distance selling depends on product and supply status. Non-prescription products remain subject to relevant conditions; prescription products face particular restrictions in Germany. A shop is not necessarily lawful because a foreign supplier operates similarly.
Assessment covers the supplier’s entitlement, labelling, required information, registered distribution channels and destination-country law. Imports and distribution partnerships require allocation of storage, returns, complaints and authority contacts. Contract enforcement also raises jurisdiction and applicable-law questions.
Adverse reactions, quality defects and recalls
Suspected incidents require a clear distinction between adverse reactions, administration problems, quality defects and other causes. Reporting, monitoring and remedial duties may arise according to role and circumstances. Animal and, where relevant, human safety must be coordinated with evidence preservation and legal communications.
We assess supply suspensions, information measures and recourse claims. Batch details, product records, findings and communications should be preserved. Premature admissions of liability can be as problematic as delayed responses to credible safety concerns.
Practice management, cooperation and business development
Veterinary businesses need clear agreements on ownership, staff, cooperation, premises, equipment and data. Acquisitions and succession require coordination of contracts, permits, ongoing treatments and financial risks. Professional rules also depend on the competent chambers and state law.
For digital and telemedicine services we examine the service description, limits, documentation and liability. The technical ability to communicate remotely does not itself establish whether a specific treatment or supply of medicines is permissible.
Authorities, civil courts and defence
For inspections and complaints we assess the file, legal basis, findings and scope of the measure. Depending on the law, adverse decisions may be challenged, including by urgent relief. Professional, administrative and criminal proceedings each require separate assessment.
Where practice managers or staff face allegations, factual statements should be coordinated with the case file. Civil claims, insurance and recourse chains are examined separately. We assist with negotiation, evidence preservation, litigation and permissible appeals.
Preparing for advice
Treatment matters require instructions, complete records, findings, invoices and a short chronology. Product matters require intended purpose, composition, authorisations, labelling, distribution arrangements and advertising. For authority correspondence, provide service dates and deadlines.
We first agree the aim and scope of legal assessment and the fee framework. During a veterinary emergency, treatment by a suitable practice or clinic takes priority; a legal enquiry does not replace care.
Legal sources and further information
Regulation (EU) 2019/6 on veterinary medicinal products · German Veterinary Medicinal Products Act · Section 30 TAMG: distance selling · Veterinary Fee Schedule (GOT)
Animal feed law · Veterinary medicine and medicinal products · Veterinary technical products
Discuss your matter with us
We advise throughout Germany and assist with cross-border matters. Please identify the product, parties, target markets and deadlines. Before accepting instructions we clarify conflicts of interest, scope and fees.
Request advice · 0511 35 73 56-0
As at 7 November 2026. This overview describes typical assessment questions; classification depends on the specific product and procedure.
In depth: product status, supply chains and marketing
Legal assessment starts with composition, intended use, mode of action and advertising claims. The supplier’s chosen name does not alone determine product status. Only then can manufacturing, marketability, labelling and distribution requirements be identified. For different species or markets, a single approach may not suffice. A certificate does not automatically answer every marketing question or release all supply-chain participants from responsibility.
Identifying and addressing disputes early
Manufacturers, importers, distributors and users may have different obligations. Supply contracts should clearly allocate specifications, changes, testing records, complaints and recall costs. When a complaint arises, affected batches or devices are identified and evidence preserved. Regulatory notification, a sales suspension or recall depends on the risk and applicable product rules. Contractual arrangements do not replace public-law duties.
Four practical examples
The following scenarios are illustrative, not accounts of actual instructions or promised outcomes. Legal assessment depends on the facts that can be established.
1. Selling a preparation online
A distributor wishes to sell a veterinary medicine online. Product status, authorisation, prescription requirements and lawful distribution channels are checked first. Permission for a physical business cannot automatically be extended to every online offer.
2. Incomplete antibiotic records
A practice has treatment records but incomplete reporting data. Species, periods and reporting obligations must be identified. Corrections should be traceable and must not conceal the original records.
3. Advertising promises a cure
A manufacturer advertises unrestricted efficacy. Permitted product information, scientific evidence and the audience are compared. Following a warning letter, correcting advertising and the scope of any undertaking to cease must be assessed separately.
4. Use outside the authorisation
An owner challenges treatment with a product authorised for another use. Whether lawful use under the cascade occurred depends on the specific conditions. Indication, available alternatives and records require clinical and legal assessment.
Documents, evidence and next steps
Labels, instructions, advertisements, specifications, test reports and supply-chain records are particularly useful. Where health damage occurs, samples, treatment histories and alternative causes should be documented. Regulatory measures, unfair competition claims and civil damages are assessed separately, with coordinated communication. A commercially sensible response may combine replacement, revised advertising, technical improvements and clear customer information.
EU veterinary medicinal product law · Send an enquiry: all fields optional